Disclosed positions

Estimated from their latest filings — positions may have changed since

$7.54M

combined est. value

Stock	Shares	Price	Value	Weight	As of
AGIOAGIOS PHARMACEUTICALS, INC.	164,548	$42.79	$7.04M	93%	2026-03-02
NTLAIntellia Therapeutics, Inc.	32,609	$15.44	$503.5K	7%	2026-06-09

AGIO

AGIOS PHARMACEUTICALS, INC.

$7.04M

164,548 sh

NTLA

Intellia Therapeutics, Inc.

$503.5K

32,609 sh

All filings on record

Every Form 4 transaction we track for this filer

all 18buys 0sells 8

Stock	Transaction	Date	~6mo later
NTLAIntellia Therapeutics, Inc.	Grant — · 9,200 sh	2026-06-09	—
AGIOAGIOS PHARMACEUTICALS, INC.	Sell $171.4K · 5,918 sh	2026-03-02	—
AGIOAGIOS PHARMACEUTICALS, INC.	Exercise — · 13,000 sh	2026-03-02	—
AGIOAGIOS PHARMACEUTICALS, INC.	Sell $239.4K · 8,267 sh	2026-03-02	—
AGIOAGIOS PHARMACEUTICALS, INC.	Exercise — · 18,000 sh	2026-03-02	—
AGIOAGIOS PHARMACEUTICALS, INC.	Sell $112.1K · 3,870 sh	2026-03-02	—
AGIOAGIOS PHARMACEUTICALS, INC.	Exercise — · 8,500 sh	2026-03-02	—
AGIOAGIOS PHARMACEUTICALS, INC.	Sell $168.8K · 6,230 sh	2025-12-30	—
AGIOAGIOS PHARMACEUTICALS, INC.	Exercise — · 12,750 sh	2025-12-30	—
AGIOAGIOS PHARMACEUTICALS, INC.	Sell $337.9K · 12,473 sh	2025-12-30	—
AGIOAGIOS PHARMACEUTICALS, INC.	Exercise — · 25,528 sh	2025-12-30	—
AGIOAGIOS PHARMACEUTICALS, INC.	Sell $406.5K · 11,085 sh	2025-08-08	—
AGIOAGIOS PHARMACEUTICALS, INC.	Exercise — · 22,691 sh	2025-08-08	—
AGIOAGIOS PHARMACEUTICALS, INC.	Sell $208.9K · 6,229 sh	2025-06-24	—
AGIOAGIOS PHARMACEUTICALS, INC.	Exercise — · 12,750 sh	2025-06-24	—
AGIOAGIOS PHARMACEUTICALS, INC.	Sell $418.3K · 12,471 sh	2025-06-24	—
AGIOAGIOS PHARMACEUTICALS, INC.	Exercise — · 25,527 sh	2025-06-24	—
NTLAIntellia Therapeutics, Inc.	Grant — · 8,000 sh	2025-06-11	—

NTLAGrant

2026-06-09 · Intellia Therapeutics, Inc.

9,200

—

AGIOSell

2026-03-02 · AGIOS PHARMACEUTICALS, INC.

$171.4K

—

AGIOExercise

2026-03-02 · AGIOS PHARMACEUTICALS, INC.

13,000

—

AGIOSell

2026-03-02 · AGIOS PHARMACEUTICALS, INC.

$239.4K

—

AGIOExercise

2026-03-02 · AGIOS PHARMACEUTICALS, INC.

18,000

—

AGIOSell

2026-03-02 · AGIOS PHARMACEUTICALS, INC.

$112.1K

—

AGIOExercise

2026-03-02 · AGIOS PHARMACEUTICALS, INC.

8,500

—

AGIOSell

2025-12-30 · AGIOS PHARMACEUTICALS, INC.

$168.8K

—

AGIOExercise

2025-12-30 · AGIOS PHARMACEUTICALS, INC.

12,750

—

AGIOSell

2025-12-30 · AGIOS PHARMACEUTICALS, INC.

$337.9K

—

AGIOExercise

2025-12-30 · AGIOS PHARMACEUTICALS, INC.

25,528

—

AGIOSell

2025-08-08 · AGIOS PHARMACEUTICALS, INC.

$406.5K

—

AGIOExercise

2025-08-08 · AGIOS PHARMACEUTICALS, INC.

22,691

—

AGIOSell

2025-06-24 · AGIOS PHARMACEUTICALS, INC.

$208.9K

—

AGIOExercise

2025-06-24 · AGIOS PHARMACEUTICALS, INC.

12,750

—

AGIOSell

2025-06-24 · AGIOS PHARMACEUTICALS, INC.

$418.3K

—

AGIOExercise

2025-06-24 · AGIOS PHARMACEUTICALS, INC.

25,527

—

NTLAGrant

2025-06-11 · Intellia Therapeutics, Inc.

8,000

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.